GIANQUINTO, ELEONORA

GIANQUINTO, ELEONORA  

SCIENZA E TECNOLOGIA DEL FARMACO  

Mostra records
Risultati 1 - 14 di 14 (tempo di esecuzione: 0.025 secondi).
Titolo Data di pubblicazione Autore(i) File
4-amino-1,2,4-triazole-3-thione as a promising scaffold for the inhibition of serine and metallo-β-lactamases 2020 Linciano P.; Gianquinto E.; Montanari M.; Maso L.; Bellio P.; Cebrian-Sastre E.; Celenza G.; Blazquez J.; Cendron L.; Spyrakis F.; Tondi D.
The allosteric interplay between S-nitrosylation and glycine binding controls the activity of human serine racemase 2021 Marchesani F.; Gianquinto E.; Autiero I.; Michielon A.; Campanini B.; Faggiano S.; Bettati S.; Mozzarelli A.; Spyrakis F.; Bruno S.
Binding of androgen-and estrogen-like flavonoids to their cognate (Non)nuclear receptors: A comparison by computational prediction 2021 D'arrigo G.; Gianquinto E.; Rossetti G.; Cruciani G.; Lorenzetti S.; Spyrakis F.
BROAD SPECTRUM METALLO beta-LACTAMASES INHIBITORS: NEW TOOLS AGAINST CLINICALLY-RELEVANT CARBAPENEMASES 2022 Lazzarato, L.; Failla, M.; Gianquinto, E.; Bersani, M.; Bertarini, L.; Verri, A.; Vascon, F.; Sannio, F.; Verdirosa, F.; Beatrice, N.; De Luca, F.; Costi, M.P.; Cruciani, G.; Docquier, J.D.; Cendron, L.; Spyrakis, F.; Tondi, D.
Can we exploit β-lactamases intrinsic dynamics for designing more effective inhibitors? 2020 Gianquinto E.; Tondi D.; D'arrigo G.; Lazzarato L.; Spyrakis F.
Chemical modulation of the 1-(Piperidin-4-yl)-1,3-dihydro-2h-benzo[d]imidazole-2-one scaffold as a novel NLRP3 inhibitor 2021 Gastaldi S.; Boscaro V.; Gianquinto E.; Sandall C.F.; Giorgis M.; Marini E.; Blua F.; Gallicchio M.; Spyrakis F.; Macdonald J.A.; Bertinaria M.
Evaluation of Porcine and Aspergillus oryzae α-Amylases as Possible Model for the Human Enzyme 2022 Mauro Marengo, Davide Pezzilli, Eleonora Gianquinto, Alex Fissore, Simonetta Oliaro-Bosso, Barbara Sgorbini, Francesca Spyrakis, Salvatore Adinolfi
Fluorescent Nitric Oxide Photodonors Based on BODIPY and Rhodamine Antennae 2019 Parisi C.; Failla M.; Fraix A.; Rolando B.; Gianquinto E.; Spyrakis F.; Gazzano E.; Riganti C.; Lazzarato L.; Fruttero R.; Gasco A.; Sortino S.
In the search for new NLRP3 inhibitors: chemical modulation of the 1-(piperidin-4-yl)-1,3-dihydro-2 Hbenzo[d]imidazole-2-one scaffold 2021 Simone Gastaldi, Valentina Boscaro, Eleonora Gianquinto, Christina F. Sandall, Marta Giorgis, Elisabetta Marini, Federica Blua, Margherita Gallicchio, Francesca Spyrakis, Justin A. MacDonald, Massimo Bertinaria
Interaction of human hemoglobin and semi-hemoglobins with the Staphylococcus aureus hemophore IsdB: a kinetic and mechanistic insight 2019 Gianquinto E.; Moscetti I.; De Bei O.; Campanini B.; Marchetti M.; Luque F.J.; Cannistraro S.; Ronda L.; Bizzarri A.R.; Spyrakis F.; Bettati S.
Iron metabolism at the interface between host and pathogen: From nutritional immunity to antibacterial development 2020 Marchetti M.; De Bei O.; Bettati S.; Campanini B.; Kovachka S.; Gianquinto E.; Spyrakis F.; Ronda L.
Repurposing the trypanosomatidic gsk kinetobox for the inhibition of parasitic pteridine and dihydrofolate reductases 2021 Santucci M.; Luciani R.; Gianquinto E.; Pozzi C.; Di Pisa F.; Dello Iacono L.; Landi G.; Tagliazucchi L.; Mangani S.; Spyrakis F.; Costi M.P.
Ten Years with New Delhi Metallo-β-lactamase-1 (NDM-1): From Structural Insights to Inhibitor Design 2019 Linciano, Pasquale; Cendron, Laura; Gianquinto, Eleonora; Spyrakis, Francesca; Tondi, Donatella
Virtual screening identifies broad-spectrum β-lactamase inhibitors with activity on clinically relevant serine- and metallo-carbapenemases 2020 Spyrakis F.; Santucci M.; Maso L.; Cross S.; Gianquinto E.; Sannio F.; Verdirosa F.; De Luca F.; Docquier J.-D.; Cendron L.; Tondi D.; Venturelli A.; Cruciani G.; Costi M.P.